08:47 AM EDT, 03/30/2026 (MT Newswires) -- MediPharm Labs ( MEDIF ) said Monday that fourth-quarter revenue dipped slightly.

Revenue fell from $12.04 million, to $11.06 million. Medipharm ( MEDIF ) said the decrease was due to "timing and mix differences."

MediPharm ( MEDIF ) ended the quarter with a cash balance of $10.8 million.

The company is also planning for continued expansion of its product portfolio and advancing opportunities in markets such as Brazil, France, and New Zealand.

"We ended 2025 stronger, with 8% revenue growth supported by 43% year over year growth in our international medical cannabis business and a robust platform designed for regulated markets," said interim chief executive Greg Hunter.

"As a result of our efforts, we exited 2025 with a more resilient and diversified revenue mix and strong balance sheet with virtually no debt and over $10 million in cash."